NY Psychiatric Institute IRB and Investigator Are Issued Warning Letters

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

NY Psychiatric Institute IRB and Investigator Are Issued Warning Letters

J.W. Schomisch

March 30, 2024 at 03:34 PM EST

The FDA sent March 21 Warning Letters to both a clinical investigator and the institutional review board (IRB) of the New York State Psychiatric Institute (NYSPI). The letters were the result of routine Bioresearch Monitoring program inspections of the clinical investigator between Dec. 19, 2022, and Jan. 10, 2023, and the IRB between Jan. 23 and Feb. 2, 2023. The Warning Le... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

NY Psychiatric Institute IRB and Investigator Are Issued Warning Letters

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT